Drugs / Florajen3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03696953 | Feb 2019 → Sep 2022 | group B streptococcal infection | Marquette University | Unknown | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Florajen3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03696953 ↗ |
| Modality | Other / unclassified | “oral probiotic combination product” NCT03696953 ↗ |
| Route | Oral | “Probiotic combination product One capsule daily by mouth.” NCT03696953 ↗ |